Literature DB >> 10427694

Nystatin effects on vacuolar function in Saccharomyces cerevisiae.

M S Bhuiyan1, Y Ito, A Nakamura, N Tanaka, K Fujita, H Fukui, K Takegawa.   

Abstract

The effects of nystatin, a polyene antibiotic, was studied in Saccharomyces cerevisiae by isolating and characterizing nystatin-sensitive mutants. We isolated a number of nystatin-sensitive mutants by ethylmethane sulfonate mutagenesis. One of these mutants, the nss1 mutant, was characterized in detail. The mutant was sensitive to stresses such as high temperature or high concentrations of monovalent and divalent cations. The nss1 mutants showed severe vacuolar protein sorting and vacuolar morphology defects. The nss1 mutant was demonstrated to have a mutational lesion in the known VPS16 gene, which is essential for vacuolar protein sorting in S. cerevisiae. All of the vacuolar deficient mutants (vps11, vps16, vps18, and vps33) were sensitive to nystatin. Nystatin was found to cause extensive enlargement of the vacuole in wild-type S. cerevisiae cells. These results are discussed with special reference to the vacuolar function of S. cerevisiae.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10427694     DOI: 10.1271/bbb.63.1075

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  7 in total

1.  An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease.

Authors:  Andrew B Munkacsi; Fannie W Chen; Matthew A Brinkman; Katsumi Higaki; Giselle Domínguez Gutiérrez; Jagruti Chaudhari; Jacob V Layer; Amy Tong; Martin Bard; Charles Boone; Yiannis A Ioannou; Stephen L Sturley
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

2.  Screening the Saccharomyces cerevisiae Nonessential Gene Deletion Library Reveals Diverse Mechanisms of Action for Antifungal Plant Defensins.

Authors:  Kathy Parisi; Stephen R Doyle; Eunice Lee; Rohan G T Lowe; Nicole L van der Weerden; Marilyn A Anderson; Mark R Bleackley
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

3.  Parallel genetic changes and nonparallel gene-environment interactions characterize the evolution of drug resistance in yeast.

Authors:  Aleeza C Gerstein; Dara S Lo; Sarah P Otto
Journal:  Genetics       Date:  2012-06-19       Impact factor: 4.562

4.  Mutations that affect vacuole biogenesis inhibit proliferation of the endoplasmic reticulum in Saccharomyces cerevisiae.

Authors:  Ann J Koning; Lynnelle L Larson; Emily J Cadera; Mark L Parrish; Robin L Wright
Journal:  Genetics       Date:  2002-04       Impact factor: 4.562

5.  Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms.

Authors:  Leandro P Bezerra; Cleverson D T Freitas; Ayrles F B Silva; Jackson L Amaral; Nilton A S Neto; Rafael G G Silva; Aura L C Parra; Gustavo H Goldman; Jose T A Oliveira; Felipe P Mesquita; Pedro F N Souza
Journal:  Antibiotics (Basel)       Date:  2022-04-21

6.  Real-time Monitoring of Non-specific Toxicity Using a Saccharomyces cerevisiae Reporter System.

Authors:  Anna-Liisa Välimaa; Anniina Kivistö; Marko Virta; Matti Karp
Journal:  Sensors (Basel)       Date:  2008-10-16       Impact factor: 3.576

7.  Chemogenomic profiling in yeast reveals antifungal mode-of-action of polyene macrolactam auroramycin.

Authors:  Jin Huei Wong; Mohammad Alfatah; Kiat Whye Kong; Shawn Hoon; Wan Lin Yeo; Kuan Chieh Ching; Corinna Jie Hui Goh; Mingzi M Zhang; Yee Hwee Lim; Fong Tian Wong; Prakash Arumugam
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.